November 17, 2021

After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer. 

If there’s one through line in this year’s report, it’s this: we are an industry working toward sustainable acceleration in the product management lifecycle. The disruption of the pandemic fueled fast-moving innovation, including untold experience cycles that showed leaders what was possible in a crisis.   

So, what worked and what didn’t? What’s repeatable and important in the now normal?

There are several key themes leading us to what’s next and they start in a critically important place: new models across the spectrum from clinical development to commercialization and everything in between. Biopharma organizations around the world are validating provisional insights hard-earned in times of rapid change to identify exactly how to best achieve efficiency and effectiveness going forward. 


Exclusive Webinar

Watch On-Demand 


Subscribe now to attend this sneak preview of the Syneos Health 2022 Health Trends, where you will: 

  • Discover the ten key trends shaping the biopharmaceutical industry in 2022 and beyond 
  • Explore the new clinical and commercial models that are emerging in a climate that is incredibly challenged 
  • Consider the implications for sponsors, healthcare practitioners, patients and other industry stakeholders 


Sign up below to receive exclusive access to the 2022 Health Trends report, newsletter and webinar.

Scroll to Page Bottom Form